EUS-guided tissue acquisition in the study of the adrenal glands: Results of a nationwide multicenter study

Background: There are limited data about the role of endoscopic ultrasound-guided tissue acquisition (EUS-TA), by fine needle aspiration (EUS-FNA) or biopsy (EUS-FNB), in the evaluation of the adrenal glands (AG). The primary aim was to assess the diagnostic yield and safety. The secondary aims were...

Descripción completa

Detalles Bibliográficos
Autores: Martín Cardona, Albert; Fernández Esparrach, Gloria; Súbtil Íñigo, José Carlos; Iglesias García, Julio; García Guix, Marta; Barturen Barroso, Angel; Gimeno García, Antonio Z.; Esteban, José Miguel; Pardo Balteiro, Albert; Velasco Guardado, Antonio; Vazquez Sequeiros, Enrique; LORAS ALASTRUEY, CARME; Martínez Moreno, Belén; Castellot Martín, Ana; Huertas Nadal, Carlos; Martínez Lapiedra, Mamen; Sánchez Yague, Andrés; Teran, Álvaro; Morales Alvarado, Víctor J.; Betés Ibáñez, Maria Teresa; Iglesia, Daniel de la; Sánchez Montes, Cristina; Lozano Escario, María Dolores; Lariño Noia, José; Ginès, Àngels; Tebe, Cristian; gornals, joan b
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2019
País:España
Institución:Universitat Oberta de Catalunya (UOC)
Repositorio:O2, repositorio institucional de la UOC
OAI Identifier:oai:openaccess.uoc.edu:10609/101699
Acceso en línea:https://hdl.handle.net/10609/101699
Nivel de acceso:Acceso abierto
Palabra clave:Endoscopic ultrasonography
Diagnosis
Ecografía endoscópica
Diagnóstico
Drainage
Surgical
Endoscopis
Drenaje quirúrgico
Descripción
Sumario:Background: There are limited data about the role of endoscopic ultrasound-guided tissue acquisition (EUS-TA), by fine needle aspiration (EUS-FNA) or biopsy (EUS-FNB), in the evaluation of the adrenal glands (AG). The primary aim was to assess the diagnostic yield and safety. The secondary aims were the malignancy predictors, and to create a predictive model of malignancy. Methods: This was a retrospective nationwide study involving all Spanish hospitals experienced in EUS-TA of AGs. Inclusion period was from April-2003 to April-2016. Inclusion criteria: all consecutive cases that underwent EUS-TA of AGs. EUS and cytopathology findings were evaluated. Statistical analyses: diagnostic accuracy of echoendoscopist's suspicion using cytology by EUS-TA, as gold standard; multivariate logistic regression model to predict tumor malignancy. Results: A total of 204 EUS-TA of AGs were evaluated. Primary tumor locations were lung 70%, others 19%, and unknown 11%. AG samples were adequate for cytological diagnosis in 91%, and confirmed malignancy in 60%. Diagnostic accuracy of the endosonographer's suspicion was 68%. The most common technique was: a 22-G (65%) and cytological needle (75%) with suction-syringe (66%). No serious adverse events were described. The variables most associated with malignancy were size>30mm (OR2.27; 95%CI, 1.16-4.05), heterogeneous echo-pattern (OR2.11; 95%CI, 1.1-3.9), variegated AG shape (OR2.46; 95%CI, 1-6.24), and endosonographer suspicion (OR17.46; 95%CI, 6.2-58.5). The best variables for a predictive multivariate logistic model of malignancy were age, sex, echo-pattern, and AG-shape. Conclusions: EUS-TA of the AGs is a safe, minimally invasive procedure, allowing an excellent diagnostic yield. These results suggest the possibility of developing a pre-EUS procedure predictive malignancy model.